4D Molecular Therapeutics Cash from Financing (TTM) Analysis

4D Molecular Therapeutics Inc (FDMT)

26.40 +1.06 (+4.16%) USD | NASDAQ | May 02, 16:00

26.40 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	156.83M
September 30, 2023	154.12M
June 30, 2023	144.02M
March 31, 2023	13.45M
December 31, 2022	3.085M
September 30, 2022	117.18M
June 30, 2022	118.70M

Date	Value
March 31, 2022	119.56M
December 31, 2021	118.09M
September 30, 2021	207.93M
June 30, 2021	206.85M
March 31, 2021	278.52M
December 31, 2020	278.98M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

3.085M

Minimum

Dec 2022

278.98M

Maximum

Dec 2020

147.49M

Average

144.02M

Median

Jun 2023

Cash from Financing (TTM) Benchmarks